Partnering for innovation in animal health

We’re focused on discovering and developing breakthroughs that tackle the most important scientific challenges we face. So we’re looking for visionary partners in both animal health and human pharma, who bring valuable new ideas and science to our collective innovation journey. This broad perspective is key to accelerating the next wave of therapeutics that will transform animal health now and in generations to come.

Our animal health partnering interests

Infectious diseases

Bacterial diseases

Viral diseases

Parasitic diseases

Parasitic diseases

Non-infectious diseases

Cardio-renal-metabolic diseases & obesity

Central nervous system diseases

Immunology & inflammation

Oncology

Oral Health

Pain & Mobility

Non-disease specific

Technologies

Digital Science

Our partnering activities include:

• Focusing on the discovery and development of innovative solutions in our scientific areas of focus
• Pursuing novel technologies to support therapeutic advances in key areas of unmet need
• Connecting across the wider scientific community to translate learnings into breakthroughs that could improve the lives of animals

We’re interested in therapeutic solutions and technologies across several areas of animal health: bacterial, viral, and parasitic diseases, as well as non-infectious issues, including cardio-renal-metabolic diseases and obesity; central nervous system diseases; immunology and inflammation; oncology; oral health; and pain and mobility.

Infectious diseases

Building on Boehringer Ingelheim’s longstanding leadership in preventive animal health care, we’re interested in collaborations that advance the next generation of vaccines and treatments for Bacterial diseases (PDF), Viral diseases (PDF), and Parasitic diseases (PDF). To see our partnering interests in these areas, please click on the links above. We’re open to a variety of partnership models to explore:

• Bacterial and viral diseases in food animal production
• Bacterial and viral diseases affecting pets
• Transboundary and emerging diseases across all species
• Novel adjuvant systems and platforms for animal health
• Prevention and treatment of ecto- and endo-parasites across all species
• Sustainable and green chemistry technologies in anti-parasitics

Connect with our team

Contact our Partnering team in infectious diseases:

We aim to respond to you within seven business days. Please note that this email address is not intended for adverse event reporting.

Non-infectious diseases

We’re actively pursuing partnerships to help address unmet needs in many non-infectious diseases that have an impact on the quality of life or the lifespan of dogs, cats, and horses. To see our partnering interests in these areas, please click on the links below.

• Cardio-renal-metabolic diseases (PDF) and obesity in cats and dogs
• Central nervous system (CNS) disorders (PDF), such as anxiety and cognitive dysfunction, in pets and horses
• Inflammatory and immunology conditions (PDF), such as osteoarthritis, dermatitis and inflammatory bowel disease
• Canine and feline oncology (PDF), exploring both cell-directed and immune pathways
• Pet oral health (PDF), such as periodontitis, especially solutions for easier administration
• Pain and mobility (PDF) issues in pets and horses, including osteoarthritis and post-surgical pain

Connect with our team

Contact our Partnering team in non-infectious diseases:

We aim to respond to you within seven business days. Please note that this email address is not intended for adverse event reporting.

Non-disease specific

Beyond the molecules and compounds that prevent and treat animal disease, we’re interested in advancing cutting-edge Technologies (PDF) and Digital Science (PDF) applications that can impact many areas of animal health. To see our partnering interests in these areas, please click on the links above. Contact us to discuss collaborating on:

• Novel or long-acting pharmaceutical delivery mechanisms that enhance ease or convenience
• Manufacturing technologies, at any stage of the process
• Innovative biotherapeutic platforms
• Communication solutions for vets and animal owners
• Data management platforms
• Digital diagnostic and monitoring tools

Connect with our team

Contact our Partnering team in technologies and digital science:

We aim to respond to you within seven business days.

Our 2025 priorities

While we’re open to partnerships in all our interest areas, in 2025 we’re especially focused on pet therapeutics, particularly allergic diseases, pain, cardio-renal-metabolic diseases, oncology, central nervous system diseases, and oral health. We’re also interested in opportunities that prevent infectious diseases in livestock.

“We truly believe that listening to and learning from each other can accelerate innovation in animal health. New ideas and new science bring critical diversity of thought and could spark the next transformative solution. Let’s work together to begin new innovation journeys and co-create the next breakthrough that could build a healthier future for animals.”

Megan Grether

Global Head of Business Development and Licensing, Animal Health

Connect with us

We’re excited to hear your ideas. Connect with our Animal Health Partnering team by email, through our online portal, or at an industry event.